Gerresheimer AG (GXI) - Cash Flow Conversion Efficiency

Latest as of May 2025: 0.042x

Based on the latest financial reports, Gerresheimer AG (GXI) has a cash flow conversion efficiency ratio of 0.042x as of May 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€62.03 Million ≈ $72.51 Million USD) by net assets (€1.47 Billion ≈ $1.71 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Gerresheimer AG (GXI) market capitalisation for the company's overall valuation and market capitalisation.

Gerresheimer AG - Cash Flow Conversion Efficiency Trend (2013–2024)

This chart illustrates how Gerresheimer AG's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Gerresheimer AG Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Gerresheimer AG ranked by their cash flow conversion efficiency. Explore earnings quality score of Gerresheimer AG to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
Shandong Longhua New Material Co. Ltd.
SHE:301149
0.012x
Shenzhen Sinovatio Technology Co Ltd Class A
SHE:002912
-0.022x
Liberty Financial Group
AU:LFG
0.040x
UEM Sunrise Bhd
KLSE:5148
0.007x
Lingyuan Iron & Steel Co Ltd
SHG:600231
-0.030x
XOMA Royalty Corporation
NASDAQ:XOMA
0.054x
Beijing Global Safety Technology Co Ltd
SHE:300523
-0.019x
Zhejiang China Light & Textile Industrial City Group Co Ltd
SHG:600790
-0.007x

Annual Cash Flow Conversion Efficiency for Gerresheimer AG (2013–2024)

The table below shows the annual cash flow conversion efficiency of Gerresheimer AG from 2013 to 2024. View GXI share price today for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-11-30 €1.54 Billion
≈ $1.80 Billion
€240.33 Million
≈ $280.97 Million
0.156x -21.89%
2023-11-30 €1.47 Billion
≈ $1.72 Billion
€294.34 Million
≈ $344.11 Million
0.200x +14.34%
2022-11-30 €1.27 Billion
≈ $1.48 Billion
€221.94 Million
≈ $259.47 Million
0.175x -17.37%
2021-11-30 €1.00 Billion
≈ $1.17 Billion
€212.08 Million
≈ $247.94 Million
0.212x -14.32%
2020-11-30 €899.66 Million
≈ $1.05 Billion
€222.19 Million
≈ $259.77 Million
0.247x +20.53%
2019-11-30 €941.56 Million
≈ $1.10 Billion
€192.92 Million
≈ $225.55 Million
0.205x +5.14%
2018-11-30 €890.13 Million
≈ $1.04 Billion
€173.47 Million
≈ $202.81 Million
0.195x -29.79%
2017-11-30 €789.52 Million
≈ $923.04 Million
€219.16 Million
≈ $256.22 Million
0.278x +22.13%
2016-11-30 €763.29 Million
≈ $892.37 Million
€173.49 Million
≈ $202.82 Million
0.227x -22.13%
2015-11-30 €698.13 Million
≈ $816.19 Million
€203.78 Million
≈ $238.24 Million
0.292x +11.45%
2014-11-30 €604.37 Million
≈ $706.57 Million
€158.29 Million
≈ $185.05 Million
0.262x +0.60%
2013-11-30 €563.40 Million
≈ $658.68 Million
€146.68 Million
≈ $171.48 Million
0.260x --

About Gerresheimer AG

F:GXI Germany Medical Instruments & Supplies
Market Cap
$1.12 Billion
€953.99 Million EUR
Market Cap Rank
#10481 Global
#1235 in Germany
Share Price
€27.62
Change (1 day)
-0.86%
52-Week Range
€15.51 - €44.18
All Time High
€120.00
About

Gerresheimer AG, together with its subsidiaries, provides medicine packaging, drug delivery devices, and solutions in Germany and internationally. The company operates through three divisions: Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. It offers prefillable syringes, plastic and glass packaging solutions, vials, glass cartridges and ampoules, bottles and containers, a… Read more